These injections are administered pre-, inter- or post- operatively.
|
CPT |
DESCRIPTION |
|
64415 |
Injection, anesthetic agent; brachial plexus, single |
|
64416 |
Injection, anesthetic agent; brachial plexus, continuous infusion by catheter (including catheter placement) |
|
64417 |
Injection, anesthetic agent; axillary nerve |
|
64418 |
Injection, anesthetic agent; suprascapular nerve |
|
64445 |
Injection, anesthetic agent; sciatic nerve, single |
|
64446 |
Injection, anesthetic agent; sciatic nerve, continuous infusion by catheter (including catheter placement) |
|
64447 |
Injection, anesthetic agent; femoral nerve, single |
|
64448 |
Injection, anesthetic agent; femoral nerve, continuous infusion by catheter (including catheter placement) |
|
64449 |
Injection, anesthetic agent; lumbar plexus, posterior approach, continuous infusion by catheter (including catheter placement) |
|
64450 |
Injection, anesthetic agent; other peripheral nerve or branch |
|
64520 |
Injection, anesthetic agent; lumbar or thoracic (paravertebral sympathetic) |
The modifiers below are approved modifiers for use with peripheral block procedures. Payment will only be made once during an episode of care. Modifier -59 is required to distinguish the block from the intraoperative anesthetic technique. This is especially important when the same provider performs the nerve block and the intraoperative anesthesia.
|
Modifier |
Description |
|
-50 |
Bilateral Procedure |
|
-59 |
Distinct Procedural Service |
|
-73 |
Discontinued Out-Patient/Ambulatory Surgery Center (ASC) Procedure Prior to the Administration of Anesthesia |
|
-74 |
Discontinued Out-Patient/Ambulatory Surgery Center (ASC) Procedure After the Administration of Anesthesia |
|
-LT |
Left side (used to identify procedures performed on the left side of the body) |
|
-RT |
Right side (used to identify procedures performed on the right side of the body) |
Learn more about GENASCIS.
The information provided should be utilized for educational purposes only. Please consult with your billing and coding expert. Facilities are ultimately responsible for verifying the reporting policies of individual commercial and MAC/FI carriers prior to claim submissions.
Read more from GENASCIS:
– Is Facility Fee Charge Waived for Medicare When Using Modifier -33
– 2011 Musculoskeletal Coding Update
– GENASCIS Announces Development of MEDIBIS Mobile
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
